These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 7530263

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Primary centroblastic/centrocytic lymphoma of the skin. Detection of B-cell monoclonality by polymerase chain reaction.
    Peris K, Caracciolo E, Weirich G, Chimenti S.
    Am J Dermatopathol; 1995 Oct; 17(5):506-10. PubMed ID: 8599458
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Histopathologic features of erythema nodosum--like lesions in Behçet disease: a comparison with erythema nodosum focusing on the role of vasculitis.
    Kim B, LeBoit PE.
    Am J Dermatopathol; 2000 Oct; 22(5):379-90. PubMed ID: 11048972
    [Abstract] [Full Text] [Related]

  • 7. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML, Almeida J, Vidriales B, López-Berges MC, García-Marcos MA, Moro MJ, Corrales A, Calmuntia MJ, San Miguel JF, Orfao A.
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Biclonal chronic lymphocytic leukemia.
    Hsi ED, Hoeltge G, Tubbs RR.
    Am J Clin Pathol; 2000 Jun; 113(6):798-804. PubMed ID: 10874880
    [Abstract] [Full Text] [Related]

  • 10. Lambda light chain predominance as a sign of emerging lymphoma.
    Bray M, Alper MG.
    Am J Clin Pathol; 1983 Oct; 80(4):526-8. PubMed ID: 6414286
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements.
    Vuillier F, Claisse JF, Vandenvelde C, Travade P, Magnac C, Chevret S, Desablens B, Binet JL, Dighiero G.
    Leuk Lymphoma; 1992 Jun; 7(3):195-204. PubMed ID: 1282428
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Monitoring circulating B cells in patients with multiple myeloma at diagnosis or in plateau phase: how prevalent is light chain isotype suppression?
    King MA, Radicchi MA.
    Br J Haematol; 1992 Jun; 81(2):218-22. PubMed ID: 1379466
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clonal chronic lymphocytic leukaemia-like B lymphocytes in the blood of patients with cutaneous T-cell disorders.
    Daenen S, van Voorst Vader PC, Blom N, Pietens J, Hollema H, Smit JW.
    Br J Haematol; 1993 Oct; 85(2):307-12. PubMed ID: 7506566
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.